Bioluminescence Imaging Reveals Dynamics of Beta Cell Loss in the Non-Obese Diabetic (NOD) Mouse Model

Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis

(2012) K. Andralojc et al.   DIABETOLOGIA

Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging

(2012) Wenxian Fu et al.   NATURE IMMUNOLOGY

Progressive Erosion of  -Cell Function Precedes the Onset of Hyperglycemia in the NOD Mouse Model of Type 1 Diabetes

(2011) D. Ize-Ludlow et al.   DIABETES

Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands

(2011) J. Virostko et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Accelerated diabetes in non-obese diabetic (NOD) mice differing in incidence of spontaneous disease

(2010) A. G. BAXTER et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Evaluation of impaired β-cell function in nonobese-diabetic (NOD) mouse model using bioluminescence imaging

(2010) Dror Sever et al.   FASEB JOURNAL

Bioluminescence Imaging in Mouse Models Quantifies β Cell Mass in the Pancreas and After Islet Transplantation

(2009) John Virostko et al.   MOLECULAR IMAGING AND BIOLOGY

Molecular Imaging of the Pancreas in Small Animal Models

(2008) John Virostko et al.   GASTROENTEROLOGY

In vivo effects of cytokines on pancreatic β-cells in models of type I diabetes dependent on CD4+ T lymphocytes

(2008) Eveline Angstetra et al.   IMMUNOLOGY AND CELL BIOLOGY

Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus

(2008) David J. Klinke   PLoS One